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ABSTRACT 
 
 
Background 
Diabetes mellitus is now globally considered as a leading 
cause of morbidity and mortality. It is associated with high 
rates of microvascular and macrovascular complications. 
Regular consumption of high caloric food, poor dietary 
habits and adoption of sedentary life style has been linked 
with the development of type 2 diabetes mellitus. 
 
Aims 
The purpose of this review is; to highlight the influence of 
diet on HbA1c in type 2 diabetics, to explore association 
between HbA1c and diabetes complications and to propose 
a dietary consultation model for more effective diabetes 
care. 
 
Methods 
The literature was reviewed intensively from January – 
March 2016 through PubMed central, Medscape, Google 
Scholar and other databases. The keywords and MeSH 
terms used in this search were “diabetes mellitus”, 
“glycated haemoglobin”, “type 2 diabetes mellitus”, “diet 
and type 2 diabetes mellitus” and “diabetes complications”. 
 
Results 
Dietary management is a superior option for glycaemic 
control in type 2 diabetes mellitus. It is important to keep 
the HbA1c level in acceptable range to delay the onset and 
progression of diabetes complications. In this review, 
various food groups that can have beneficial and adverse 
effects on HbA1c have been identified. Moreover, Diabetic 
Retinopathy (DR) stood out as the most prevalent 
complication of poorly managed diabetes mellitus in Saudi 
Arabia. 
 
Conclusion 
The dimensions of the proposed dietary consultation model 
are based on the assessment of diabetics’ diabetes mellitus 
knowledge, dietary knowledge, dietary attitude and dietary 
practices. This assessment if carried out at the initial stage 
of Diabetes mellitus can be helpful in delaying the early 
onset and progression of microvascular and macrovascular 
diabetes complications. 
 
Key Words 
Glycaemic control, diabetes complications, diet, type 2 
diabetes mellitus 
 
What this review adds:  
Dietary management is considered as a corner stone in the 
management of type 2 diabetes mellitus. Therefore, in this 
review, link between diet, HbA1c and diabetic complications 
have been presented. The review concludes by proposing a 
dietary consultation model for more effective diabetes care. 
The consultation model if used at an initial stage of Diabetes 
mellitus can be useful in delaying the early onset and 
progression of diabetes complications 
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1. What is known about this subject?  
Globally, Diabetes mellitus is one of the leading causes of 
morbidity and mortality and is associated with high rates of 
vascular complications. 
 
2. What new information is offered in this review? 
A relatively new dietary consultation model has been 
proposed in this review for more effective diabetes care. 
 
3. What are the implications for research, policy, or 
practice?  
Improvement in management of type 2 diabetes can be 
achieved if special emphasis is given on diabetics’, diabetes 
mellitus & dietary knowledge, dietary attitude and dietary 
practices.  
 
Introduction 
Globally, Diabetes mellitus (DM) is now considered as a 
leading cause of morbidity and mortality. Diabetes mellitus 
is associated with high rates of microvascular and 
macrovascular complications. Throughout the world, 
Diabetes mellitus is rated as one of the most common non-
communicable diseases.
1
 In the last few decades, especially 
in the developing world, diabetes is the fourth leading cause 
of deaths.
2
 Currently, worldwide Diabetes mellitus has 
affected approximately 240 million people and by 2025 this 
number is expected to reach 380 million.
3
 Increase in the 
incidence of Diabetes mellitus at this pace is creating an 
alarming situation that can have serious long term 
consequences and presents as a challenge for healthcare 
stakeholders. Six Arab speaking countries namely; Saudi 
Arabia, Kuwait, Qatar, Lebanon, Bahrain and United Arab 
Emirates are among the world’s top countries with the 
highest prevalence of type 2 Diabetes mellitus (T2DM) 
affecting 32.8 million people in 2011, which is expected to 
increase to 60 million by 2030. Diabetes affects almost 
every organ of the body and causes serious complications 
like stroke, heart attack, kidney disease, gangrene, 
blindness and renal failure.
4
 Many risk factors have been 
associated with diabetes and its complications such as diet, 
sedentary life-style, age, obesity and genetic profile of a 
person.
5–7
 Moreover, ill effects of intensive therapy on 
microvascular complications of diabetes is suggestive of 
choosing some way to control hyperglycaemia by moderate 
treatment with both diet and medication.
8
  
 
The principal step in the management of Diabetes mellitus 
is to train the patients in self-management care to prevent 
the early onset of diabetes complications. Dietary 
management is considered as a corner stone in the 
management of type 2 Diabetes mellitus; therefore, in this 
review, we have tried to highlight the impact of diet on 
HbA1c in type 2 diabetics, including association between 
HbA1c and diabetes complications, and conclude by 
proposing a dietary consultation model for more effective 
diabetes care. 
 
Impact of carbohydrate intake on HbA1c 
A randomized controlled trial carried out by Foster
9
 stated 
that diabetics consuming a low carbohydrate diet had a 
significant weight loss as compared to diabetics who were 
on a conventional diet. A study conducted in women 
reported that carbohydrates like rice and barley had 
harmful effects on HbA1c.
10
 Another study conducted on 
type 2 Diabetes mellitus patients revealed that low 
carbohydrate and low fat hypo-caloric diets led to an 
improvement in HbA1c level.
11
 Shadman
12
 suggested that 
type 2 diabetics on low carbohydrate & low saturated fat 
diet had better glycaemic control. Hajime
13
 reported that 
restricting carbohydrate diet to 45 per cent led to a greater 
reduction in HbA1c as compared to diets high in 
carbohydrates. Study conducted by Arora
14
 concluded that 
during 5 weeks dietary intervention HbA1c decreased 
significantly on limiting the carbohydrates consumption 
between 40–55 per cent. 
 
Impact of protein (meat & fish) intake on HbA1c 
A systematic review of 12 cohort studies stated that 
consuming red meat more than three times a week 
significantly increases the risk of type 2 Diabetes mellitus.
15
 
A longitudinal study conducted in men by Van Dam
16
 
reported that increased consumption of processed meat 
was related with a higher risk for type 2 Diabetes mellitus 
(relative risk=1.46, for more than five times a week vs. less 
than once per month, p<0.0001). Gross
17
 suggested that 
limiting the amount of red meat as compared to chicken 
had a significant effect on HbA1c, fasting blood glucose 
(FBG), low density lipoprotein – cholesterol (LDL-C), and 
high density lipoprotein – cholesterol (HDL-C). In women 
with, type 2 Diabetes mellitus, frequent intake of red meat 
as compared to chicken was related with high risk of 
coronary heart disease (CHD) (p<0.001).
18
 From previous 
studies, it has been reported that the eating of fish, 
especially long chain omega 3 fatty acids have several 
beneficial metabolic effects in diabetics. Wallin
19
 concluded 
from his study conducted on type 2 Diabetes mellitus 
patients that consuming fish had positive effects on their 
glycaemic control, glucose tolerance and microalbuminuria. 
Another study conducted on type 2 Diabetes mellitus 
patients reported that regular consumption of fish 
improved HbA1c level.
20
 
 
 348 
 
[AMJ 2016;9(9):346–356] 
 
 
Impact of fatty acids on HbA1c 
In comparison to dietary macronutrients distribution 
recommendation, intake of carbohydrates, total and 
saturated fat was found to be high in Saudi Arabia and other 
Gulf Cooperation Council (GCC) countries.
21
 This 
composition of the diet was also compared to an Iranian 
study that showed Iranian patients had high calorie intake 
and also consumed foods high in fat. Otherwise stated, 
increase in calorie intake was associated with the intake of 
foods high in fat (butter, margarine, cheese etc.) and greasy 
foods (polyunsaturated fatty acids).
22
 Many studies have 
documented a valuable effect of high monounsaturated 
fatty acids (MUFA) diets in prevention and management of 
Diabetes mellitus.
23–25
 A meta-analysis compared the effect 
of high MUFA versus low MUFA diet (less than 12 per cent 
vs. more than 12 per cent) on HbA1c level in participants 
with elevated glucose reported that a high MUFA diet was 
more effective in reducing HbA1c level as compared to a 
low MUFA diet.
26
 
 
Improved HbA1c through high fibre intake 
Various studies have reported that high intake of fibre has a 
positive effect on HbA1c. Fujii
27
 conducted a study in 
Japanese type 2 diabetics stated that diabetics should be 
encouraged to consume diets high in fibre on a daily basis 
because of their beneficial effect on HbA1c and it also 
lowers the risk of CHD. Another study conducted by 
Chandalia
28
 in type 2 diabetics concluded that consumption 
of soluble dietary fibre, as recommended by the American 
Diabetes Association (ADA), improves glycaemic control, 
and decreases hyperinsulinemia. Mcintosh
29
 conducted a 
study in a group of type 2 diabetic patients and reported 
that decline in HbA1c values and lipid profile was observed 
in patients on a high fibre diet. Patients on high fibre diets 
also had a significantly lower risk of cardiovascular diseases 
(CVD), microvascular and macrovascular complication of 
Diabetes mellitus. Allick
30
 stated in his study conducted on 
type 2 diabetic patients that a high fibre diet was associated 
with low concentrations of HbA1c as compared to low and 
saturated fat diet.  
 
Impact of polyunsaturated fats intake on HbA1c and type 2 
Diabetes mellitus 
Various studies conducted on type 2 diabetics have 
reported association between nuts consumption and their 
beneficial effect on HbA1c. Nuts improve insulin 
homeostasis and serum glucose concentration; they are 
well known to be rich in unsaturated oils. A study conducted 
by Jiang
31 
in type 2 diabetics stated that increased intake of 
nuts and peanut butter had numerous positive effects on 
glycaemic control. The study further concluded that nuts 
consumption was significantly associated with lower risk of 
CHD. The findings of a cohort study reported that 
participants who consumed nuts more than four times per 
week or more had 26 per cent less chances of developing 
diabetes as compared to those who rarely or never 
consumed nuts.
32
 A systematic review and meta-analysis 
was conducted by Viguiliouk
33
 to study the effect of tree 
nuts on glycaemic control of type 2 diabetics. Pooled 
analysis results revealed that consuming nuts had 
significantly improved HbA1c level of type 2 diabetics. 
According to another study, an increased intake of 
polyunsaturated fats was associated with a lower risk of 
type 2 Diabetes mellitus.
34
  
 
Impact of dairy products on HbA1c 
Studies have reported that intake of dairy products leads to 
positive effects on weight, glycemic control and CVD.
35,36
 
However, there is a scarcity of literature relating frequency 
of dairy intake and control of diabetes. A study conducted 
by Mizoue
37
 found that low fat dairy products had beneficial 
effect on glycemic control. Calcium and Vitamin D deficiency 
have harmful effect on glycaemia, whereas the combined 
effect of these supplementations is beneficial in enhancing 
glucose metabolism.
38
 According to Liu
39
 men and women 
who consume low fat dairy products have a lower risk of 
developing type 2 Diabetes mellitus. A meta-analysis 
conducted on dairy products and the risk of type 2 diabetes 
showed that there was a significant inverse relationship 
between intake of low fat dairy products, and cheese with 
the risk of type 2 Diabetes mellitus.
40
 
 
Impact of fruits and vegetables on HbA1c 
Various studies have reported that consuming fruits and 
vegetables are helpful in decreasing the risk of Diabetes 
mellitus. Moreover in type 2 Diabetes mellitus, fruits and 
vegetables are also beneficial in maintaining good glycaemic 
control.
41–43
 Study conducted by Franz
44
 reported that 
increased intake of vegetables and fruits significantly 
decreased HbA1c level. However, the same study also 
reported that vegetable intake significantly decreased 
Triglyceride (TG) levels (p<0.001). A systematic review and 
meta-analysis conducted by Carter
45
 concluded that 
consuming vegetables and fruits in an increased amount 
had a significant effect on body mass index (BMI), TG and 
HbA1c. In Japan, for the treatment of Diabetes mellitus, it 
was recommended that consuming at least 300g of 
vegetables daily can lead to significant decrease in HbA1c 
levels.
46
 A study done by Hamer
47
 on diabetic patients 
reported a significant effect of a semi-vegetarian and full 
vegetarian diet on glycaemic control. Patients on a semi-
vegetarian diet had lower fasting plasma glucose levels; 
whereas, patients on a full vegetarian diet had 
significant lower HbA1c levels. More studies that 
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investigated the association between vegetables and fruits 
intake and Diabetes mellitus concluded that the onset of 
diabetes can be prevented by increasing the intake of 
vegetables and fruits.
48,49
 
 
Impact of legumes on HbA1c 
Low glycemic index (LGI) foods (beans, lentils and 
chickpeas) have been shown to improve glycemic control in 
patients with type 2 Diabetes mellitus. Legumes have also 
been included in the International Diabetes Guidelines, 
2013. Legumes comprise of various nutrients including 
dietary fiber, oligosaccharides, vegetable protein, complex 
carbohydrates and minerals. A randomized controlled trial 
reported that incorporation of legumes in the diet of type 2 
diabetics had a significant beneficial effect on HbA1c.
50 
Shoff
51
 stated that foods with LGI such as legumes are 
beneficial for diabetic patients. Another study by Wolever
52
 
also reported a beneficial effect of a LGI diet on HbA1c in 
treatment of T2DM.  
 
Impact of drinks on HbA1c and type 2 Diabetes mellitus 
Consumption of sweetened beverages (soft drinks, fruit 
drinks, iced drinks, energy drinks and vitamin water drinks) 
has risen across the globe. Consuming soft drinks and other 
sweetened beverages can significantly increase the risk of 
obesity and type 2 Diabetes mellitus.
53
 A prospective study 
conducted in a Chinese population reported that consuming 
soft drinks more than two times per day has a relative risk 
of 1.42 for type 2 Diabetes mellitus.
54
 It further concluded 
that consuming 200 ml of soft drinks had a significant effect 
on blood sugar levels. The results from meta-analysis based 
on eight cohort studies revealed that persons who consume 
soft drinks more than three times per day had 26 per cent 
more chance to develop type 2 Diabetes mellitus as 
compared to those who consume soft drinks less than once 
a day.
55
  
 
A study conducted in Saudi Arabia among type 2 diabetics 
reported that 75 per cent of the patients had HbA1c above 
the normal range, and the median consumption of soft 
drinks was three (range 1–5) times per day.
56
 Salazar
57
 
studied the relation between coffee consumption and risk 
of type 2 Diabetes mellitus and, the findings revealed that 
long term coffee consumption significantly lowers the risk of 
type 2 Diabetes mellitus. Over the past few decades, 
globally the consumption of energy drinks (red bull, power 
horse etc.) has increased dramatically. Several studies have 
reported adverse effect of energy drinks on health 
especially in adolescents. Moreover, it increases the risk of 
obesity, type 2 Diabetes mellitus and has a direct effect on 
blood sugar levels.
58
 In Saudi Arabia, consumption of energy 
drinks is on the rise. Studies conducted in Dammam, 
Makkah, and Jeddah among university students revealed 
that more than 50 per cent of the students (males and 
females) consumed energy drinks more than twice per 
day.
58-60
  
 
Pathophysiology of HbA1c 
Metabolic abnormalities cause overproduction of reactive 
oxygen species (ROS). In turn, ROS, via endothelial 
dysfunction and inflammation, plays a major role in 
precipitating diabetic vascular disease.
61
 The alterations in 
vascular homeostasis due to endothelial and smooth muscle 
cell dysfunction are the main features of diabetic 
vasculopathy favouring a pro-inflammatory/thrombotic 
state which ultimately leads to atherothrombosis. Macro- 
and microvascular diabetic complications are mainly due to 
prolonged exposure to hyperglycaemia clustering with other 
risk factors such as arterial hypertension, dyslipidaemia as 
well as genetic susceptibility. Interestingly, nephropathy, 
retinopathy, and diabetic vascular disease are in line with 
the notion that endothelial, mesangial, and retinal cells are 
all equipped to handle high sugar levels when compared 
with other cell types.
62
 
 
Link between diet and HbA1c 
HbA1c is an index of average glucose (AG) over the 
preceding weeks-to-months. Erythrocyte (red blood cell) 
life-span averages about 120 days. The level of HbA1c at any 
point in time is contributed to by all circulating 
erythrocytes, from the oldest (120 days old) to the 
youngest. However, HbA1c is a “weighted” average of blood 
glucose levels during the preceding 120 days, meaning that 
glucose levels in the preceding 30 days contribute 
substantially more to the level of HbA1c than do glucose 
levels 90–120 days earlier. There is a very predictable 
relationship between HbA1c and AG. Understanding this 
relationship can help patients with diabetes and their 
health-care providers set day-to-day targets for AG based 
on HbA1c goals and it is important to remember that HbA1c 
is a weighted average of glucose levels during the preceding 
four months. Unless the patient’s glucose levels are very 
stable month after month, quarterly measurement is 
needed to insure that a patient’s glycaemic control remains 
within the target range.
63
 
 
Association between HbA1c and diabetes complications 
Good glycaemic control minimizes the risk of developing 
microvascular and macrovascular diabetes complications 
and is also helpful in delaying their progression.
64
 HbA1c has 
a very strong association with the onset of diabetes 
complications, and moreover, the progression of 
complications can be slowed if HbA1c is well maintained 
during the early stage of Diabetes mellitus.
65
 In patients 
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with type 2 Diabetes mellitus, the risk of diabetes 
complications was strongly associated with glycaemic 
control. Any reduction in HbA1c was likely to reduce the risk 
of complications.
66
  
 
Diabetic Nephropathy 
The incidence of end stage renal disease (ESRD) has 
increased dramatically in the Western world. However, its 
progression is still slow in the European countries.
67
 The 
findings of a seven year follow-up study showed that 
uncontrolled lipid profile, blood pressure and HbA1c 
significantly predicted the progression of diabetic 
nephropathy (DN).
68
 In type 2 diabetics with nephropathy, 
HbA1c and microalbuminuria were significantly positively 
correlated; this correlation showing that diabetic patients 
were progressing towards ESRD.
69
 Keane
70
 reported that in 
type 2 diabetic patients with nephropathy, proteinuria, and 
a degree of renal failure, serum albumin, and haemoglobin 
level were independent risk factors to predict renal 
outcomes. Results of a double blinded randomized 
controlled trial revealed that elevated blood pressure, total 
cholesterol and HbA1c predicted an 8.1 fold increased risk 
for progression towards ESRD. Data from Saudi Arabia 
regarding the prevalence of diabetic nephropathy is scarce. 
However, according to a study 30–45 per cent of patients on 
dialysis were diabetics.
71
 One study in Saudi Arabia 
retrospectively analysed 25 years data (1989–2004) of type 
2 diabetic patients to identify the factors affecting the 
progression of diabetic nephropathy. The study concluded 
that diabetic nephropathy tends to be progressive among 
Saudis, with glomerular filtration rate (GFR) deteriorating at 
a rate of 3.3mL/year and with a doubling of serum 
creatinine level in 40.3 per cent of patients in 9.9 years.
72
 
 
Cardiovascular Diseases 
Various epidemiological studies have shown a relationship 
between HbA1c and cardiovascular events in patients with 
type 2 Diabetes mellitus.
73
 A study conducted by Stratton
66
 
stated that after adjustment for other risk factors, an 
increase of one per cent in the HbA1c was associated with 
an increase of 18 per cent risk of cardiovascular events, an 
increase of 12–14 per cent in the risk of death, and an 
increase of 37 per cent in the risk of retinopathy or renal 
failure. Mortality from coronary artery disease was 
significantly more in type 2 diabetics with HbA1c more than 
eight per cent as compared to those having HbA1c level less 
than 8 per cent (p<0.001).
74
  
 
A randomized controlled trial evaluated two cardiac 
treatment strategies and two glycaemic treatment 
strategies in patients who were receiving uniform glycaemic 
control and intensive therapy for cardiac risk factors. The 
trial concluded that there was no significant difference in 
the rates of death and major cardiovascular events between 
patients undergoing prompt revascularization and those 
undergoing medical therapy or between strategies of insulin 
sensitization and insulin provision.
75
  
 
A study conducted in Saudi Arabia reported that HbA1c is 
not only a useful biomarker of long-term glycaemic control 
but also a good predictor of lipid profile. Thus, monitoring of 
glycaemic control through HbA1c have additional benefits 
of identifying diabetic patients who are at a greater risk of 
cardiovascular complications.
76
 It was also reported that 
among Saudis, glucose intolerance is a major risk factor for 
vascular events, especially cerebrovascular disease and 
myocardial infarction. 
 
Diabetic Neuropathy 
The Diabetes Control and Complications Trial (DCCT) has 
shown that in diabetic patients, the risk of diabetic painful 
neuropathy (DPN) and autonomic neuropathy can be 
reduced with improved blood glucose control. Although 
data from a small number of trials are much less strong for 
type 2 diabetic patients, DCCT data and data from 
epidemiologic studies including studies of type 2 patients 
strongly suggest that optimal blood glucose control helps to 
prevent DPN and autonomic neuropathy in both type 1 and 
type 2 diabetic patients.
77,78
 A study done by Tesfaye
79
 
concluded that age, duration of diabetes and glycaemic 
control were significantly associated with progression of 
diabetic neuropathy (DN). The results of a randomized 
controlled trial revealed that drugs that reduced HbA1c 
level to 6.5 per cent yielded a 21 per cent relative reduction 
in DN.
80
 In Saudi Arabia, a rapid rise in prevalence of DN was 
also observed. In 1998 the prevalence of DN was 22.7 per 
cent and 31.4 per cent in 2010.
81,82
 In another study 
conducted in Saudi Arabia, old age, long duration of type 2 
Diabetes mellitus, poor glycaemic control and smoking were 
risk factors associated with symptomatic diabetic 
neuropathy (p<0.001, p=0.09, p<0.001, p=0.04, p=0.08) 
respectively.
83
 
 
Diabetic Retinopathy 
A study done by Yun
84
 on association between diabetic 
retinopathy (DR) and HbA1c concluded that DR was 
significantly more in patients having higher levels of HbA1c 
(odds ratio: 3.46). Moreover, DR was more prevalent in 
patients with duration of diabetes less than 10 years. 
Buscemi
85 
stated that hyperglycaemia is associated with the 
progression of DR. Furthermore, HbA1c is a good indicator 
of glycaemic control as it can help diabetic individuals in 
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deterrence of microvascular complications especially DR. 
According to the study conducted by Hou
86
 less than 50 per 
cent of the participants had heard of HbA1c and 17 per cent 
had actually understood its true meaning. It shows that 
knowledge of diabetics regarding Diabetes mellitus is also 
an important factor to consider. Severity of progression 
from NPDR to PDR with respect to HbA1c values have been 
studied by many authors and almost all of the studies were 
in accord and pointed out that elevated glycaemic control 
resulted in worsening of DR.
87–89
 In addition, a population 
based study in Chennai conducted in 2008 concluded that 
type 2 diabetics having HbA1c more than eight per cent 
gave maximum capitulate to vision-loss-retinopathies.
90
 DR 
is emerging rapidly as one of the commonest causes of 
blindness. Worldwide, there are 37 million cases of 
blindness of which DR accounts for 4.8 per cent of the 
cases.
91
 DR is also highly prevalent in Middle East and Asian 
countries, A DR prevalence of 19 per cent was reported in 
the United Arab Emirates. In Kuwait it was 23.5 per 
cent, Oman 13.4 per cent, India 16.6 per cent, Pakistan 14.7 
per cent, Egypt 32.8 per cent, Jordan 34.1 per cent and in 
Malaysia it was 14.3 per cent.
92
 
 
The first study to report the prevalence of DR in Saudi 
Arabia was conducted in the Asser region and that revealed 
a prevalence of 11.3 per cent. The study further concluded 
that the DR was more among patients living in urban areas 
as compared to their rural counterparts.
93
 A study 
conducted in Al-Madina Al-Munawarah, Saudi Arabia 
reported a DR prevalence of 31 per cent.
94
 Al-Shehri
95
 
studied the Quality of Life of Saudi diabetics who were 
affected by diabetic retinopathy, nephropathy, neuropathy 
and diabetic foot. DR had the highest prevalence (42.5 per 
cent) as compared to nephropathy (10.8 per cent), 
neuropathy (28.35 per cent) and diabetic foot (five per 
cent). Moreover, patients with DR reported worst quality of 
life as compared to other complications. In another study 
conducted by Al-Ghamdi
96
 in Taif, Saudi Arabia, the 
reported prevalence of DR was 36.8 per cent of which 17.5 
per cent diabetics had sight threatening DR (STDR). 
Recently, in 2016 a study conducted in Saudi Arabia has 
found 36.4 per cent DR prevalence among the type 2 
diabetics. The ocular complication consisted of early mild 
non-proliferative diabetic retinopathy (NPDR), moderate 
NPDR and PDR, the prevalence of which were 13.0 per cent, 
5.3 per cent and 1.4 per cent respectively.
97
 A report 
published by Irfan
98
 in Arab News reported that Saudi 
Arabia spends approximately SR 30 billion every year on the 
treatment of diabetes. If there are no diabetes 
complications a patient’s treatment costs the government 
SR 5,000 per year. The treatment of one common diabetes 
complication, diabetic retinopathy, renal failure and 
cardiovascular diseases costs the government between SAR 
98,000–180,000 thousand per year for only one patient. 
 
Discussion 
Review of the literature highlights the importance of diet in 
the management of type 2 Diabetes mellitus. Diet low in 
carbohydrate is helpful in maintaining good glycaemic 
control. Use of more polyunsaturated fats should be 
emphasized instead of saturated fats. Frequent intake of 
moderate-to-high protein diet is recommended after 35–40 
years of age. Consumption of red meat more than three 
times a week significantly increases the risk of type 2 
Diabetes mellitus. Whereas, regular consumption of 
legumes in all populations is associated with good glycaemic 
control in diabetics, sweetened beverages significantly raise 
the HbA1c level. Low fat dairy products and increased 
intake of fruits and vegetables by diabetics are also 
beneficial in maintaining good glycaemic control. 
Mediterranean diet which is mainly based on consumption 
of virgin olive oil leads to the reduction in progression of 
type 2 diabetic retinopathy. Elevated HbA1c level has a 
significant influence on both microvascular and 
macrovascular diabetes complications. This review also 
highlights that physicians should encourage diabetics for 
routine eye evaluations so as to detect early ocular 
complications that may arise from Diabetes mellitus.. The 
presence of DR can also predict the presence of other 
diabetes complications like diabetic nephropathy and CVD. 
Awareness regarding a healthy diet should be provided 
through nutrition intervention programme. In addition, 
nutrition clinics should be setup at primary healthcare level 
to guide the patients at initial and individual level. 
Henceforth, to reduce the incidence of type 2 Diabetes 
mellitus and its chronic complications, it is the need of the 
hour to pay special emphasis to dietary assessment of type 
2 diabetics.  
 
Dietary consultation model for diabetes care 
There are various proposed consultation models and 
frameworks for the management of Diabetes mellitus. 
There is not much evidence that any one model is better 
than another; they are all valid and useful in different ways. 
There is also duplication between them. After all they are 
models based on the same fundamental activity, but with 
different emphasis related to their origins.
99
 The healthcare 
providers can select and use a part of any model which they 
think can help in better management of Diabetes 
mellitus.
100
 The principal step in the management of 
Diabetes mellitus is to the train the patients in self-
management care to prevent them from developing early 
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microvascular and macrovascular diabetes complications. 
Dietary management is considered as a corner stone in the 
management of Diabetes mellitus. Figure (1.1) shows a 
dietary consultation model for diabetes care that has been 
proposed in this article. This proposed dietary consultation 
model is relatively different from the already available 
diabetes consultation models. Six influential factors, 
Diabetes mellitus knowledge, dietary knowledge, dietary 
attitude, dietary practices, HbA1c and diabetes 
complications have been identified. In other words, to delay 
the early onset and progression of diabetes complications, 
the healthcare provider should pay special emphasis to 
patients “Diabetes mellitus knowledge, dietary knowledge, 
dietary attitude and dietary practices”. There exists a 
relationship between the identified factors that has been 
discussed in a separate article by the same authors. 
 
Figure 1: Dietary consultation model for diabetes care 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion  
Dietary management is a superior option for glycaemic 
control in type 2 Diabetes mellitus. It is important to keep 
the HbA1c level in an acceptable range to delay the onset 
and progression of diabetes complications. In this review, 
various food groups that can have beneficial and adverse 
effects on HbA1c have been identified. Diabetic Retinopathy 
stood out as the most prevalent complication of poorly 
managed Diabetes mellitus in Saudi Arabia. The dimensions 
of the proposed consultation model are based on the 
assessment of diabetics’ Diabetes mellitus knowledge, 
dietary knowledge, attitude and practices. This assessment 
if carried out at the initial stage of Diabetes mellitus can be 
helpful in delaying the early onset and progression of 
microvascular and macrovascular diabetes complications. 
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